Australian Sigma Pharmaceuticals Gets Bids for Two Drug Arms

Reuters -- Australia's Sigma Pharmaceuticals (SIP.AX) has received three bids for its Herron drugs arm and three bids for its Orphan Australia drugs business, as it seeks an improved bid from South Africa's Aspen Pharmacare (APNJ.J), a newspaper reported on Monday.

Back to news